Author

J. H. Rueschoff

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 3 Research Focus:cell type annotation· 2 Research Focus:cell-cell communication· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:clustering· 1

Frequent Co-Authors

C. Fankhauser· 2 shared C. Poyet· 2 shared T. Hermanns· 2 shared A. Anees· 1 shared A. Beyer· 1 shared A. Hariharan· 1 shared A. Jacobs· 1 shared A. T. Aref· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

C. Fankhauser

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Proteomic-based stratification of intermediate-risk prostate cancer patients

Q. Zhong, S. Rui, A. T. Aref, Z. Noor, A. Anees, Y. Zhu, N. Lucas, R. C. Poulos, M. Lyu, T. Zhu, B. Wang, G.-B. Chen, Y. Wang, X. Ding, D. Rutishauser, , P. J. Wild

The paper identifies an 18-protein signature from proteomic data to stratify intermediate-risk prostate cancer patients into low- and high-risk groups for biochemical recurrence.

bioRxiv · Mar 3, 2023Cancer Biology

Heterogeneity of RNA editing in mesothelioma and how RNA editing enzyme ADAR2 affects mesothelioma cell growth, response to chemotherapy and tumor microenvironment

A. Hariharan, W. Qi, H. Rehrauer, L. Wu, M. Ronner, M. Wipplinger, J. Kresoja-Rakic, S. Sun, L. Oton-Gonzales, M. Sculco, V. Serre-Beinier, C. Meiller, C. Blanquart, J.-F. Fonteneau, B. Vrugt, , E. Felley-Bosco

This study examines RNA editing heterogeneity in mesothelioma and shows ADAR2's role in cell growth, chemotherapy response, and tumor microenvironment regulation.

bioRxiv · Jul 12, 2022Cancer Biology

Single-Cell Proteomics Defines the Cellular Heterogeneity of Localized Prostate Cancer

L. De Vargas Roditi, A. Jacobs, J. H. Rueschoff, P. Bankheac, S. Chevrier, H. Jackson, T. Hermanns, C. Fankhauser, C. Poyet, F. Chun, A. Tschaebunin, B. Bodenmiller, P. Wild

This study uses single-cell proteomics to identify cellular heterogeneity in localized prostate cancer and discovers rare subpopulations associated with advanced disease.

bioRxiv · Jan 25, 2021Cancer Biology